Studies on the alleviating effect of Bifidobacterium lactis V9 on dextran sodium sulfate-induced colitis in mice

BackgroundInflammatory bowel disease (IBD) has become a global public health problem with complex pathogenesis and limited therapeutic options. We aimed to investigate the potential mechanisms by which Bifidobacterium lactis V9 (V9) alleviated colitis in a dextran sodium sulfate-induced colitis mode...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyan Duan, Rilige Wu, Jianbo Li, Zeya Li, Yanqi Liu, Ping Chen, Bangmao Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1496023/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589867166466048
author Xiaoyan Duan
Xiaoyan Duan
Xiaoyan Duan
Xiaoyan Duan
Rilige Wu
Jianbo Li
Jianbo Li
Zeya Li
Yanqi Liu
Ping Chen
Bangmao Wang
Bangmao Wang
Bangmao Wang
author_facet Xiaoyan Duan
Xiaoyan Duan
Xiaoyan Duan
Xiaoyan Duan
Rilige Wu
Jianbo Li
Jianbo Li
Zeya Li
Yanqi Liu
Ping Chen
Bangmao Wang
Bangmao Wang
Bangmao Wang
author_sort Xiaoyan Duan
collection DOAJ
description BackgroundInflammatory bowel disease (IBD) has become a global public health problem with complex pathogenesis and limited therapeutic options. We aimed to investigate the potential mechanisms by which Bifidobacterium lactis V9 (V9) alleviated colitis in a dextran sodium sulfate-induced colitis model mice.MethodsMice were induced to develop colitis by drinking DSS solution to induce colitis. The expression of the relevant factors in the blood supernatant of the mice was determined by ELISA. RT-qPCR and Western blotting were used to detect mRNA and protein expression of target genes. The fecal microbiota was analyzed by 16S rRNA sequencing. Intestinal metabolites were analyzed by untargeted metabolomics;ResultsV9 effectively improved the overall symptoms of the colitis model mice. H&E showed that V9 re-stored the intestinal tissue structure. ELISA showed that V9 decreased the levels of IL-6, IL-22, and TNF-α and increased IL-10, SP, VIP, and 5-HT. V9 increased the expression of AHR, CYP1A1, MUC2, Claudin-3, Occludin, and ZO-1, and decreased 5-hydroxytryptamine transporter and Claudin-2. V9 increased the abundance of gut microbiota in colitis mice to promote the growth of beneficial bacteria. V9 increased tryptophan metabolites, and short-chain fatty acids, and improved gut inflammation.ConclusionV9 attenuates intestinal inflammation, improves the mucosal barrier, modulates intestinal microecology and exerts a protective effect in a mouse model of DSS-induced colitis.
format Article
id doaj-art-bb497e4290bc4c53933930e2a0debc89
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-bb497e4290bc4c53933930e2a0debc892025-01-24T07:13:43ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011210.3389/fmed.2025.14960231496023Studies on the alleviating effect of Bifidobacterium lactis V9 on dextran sodium sulfate-induced colitis in miceXiaoyan Duan0Xiaoyan Duan1Xiaoyan Duan2Xiaoyan Duan3Rilige Wu4Jianbo Li5Jianbo Li6Zeya Li7Yanqi Liu8Ping Chen9Bangmao Wang10Bangmao Wang11Bangmao Wang12Department of Gastroenterology, General Hospital, Tianjin Medical University, Tianjin, ChinaTianjin Institute of Digestive Diseases, Tianjin, ChinaTianjin Key Laboratory of Digestive Diseases, Tianjin, ChinaDepartment of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, ChinaDepartment of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, ChinaDepartment of Nuclear Medicine, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, ChinaInner Mongolia Key Laboratory of Molecular Imaging, Hohhot, ChinaDepartment of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, ChinaDepartment of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, ChinaDepartment of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, ChinaDepartment of Gastroenterology, General Hospital, Tianjin Medical University, Tianjin, ChinaTianjin Institute of Digestive Diseases, Tianjin, ChinaTianjin Key Laboratory of Digestive Diseases, Tianjin, ChinaBackgroundInflammatory bowel disease (IBD) has become a global public health problem with complex pathogenesis and limited therapeutic options. We aimed to investigate the potential mechanisms by which Bifidobacterium lactis V9 (V9) alleviated colitis in a dextran sodium sulfate-induced colitis model mice.MethodsMice were induced to develop colitis by drinking DSS solution to induce colitis. The expression of the relevant factors in the blood supernatant of the mice was determined by ELISA. RT-qPCR and Western blotting were used to detect mRNA and protein expression of target genes. The fecal microbiota was analyzed by 16S rRNA sequencing. Intestinal metabolites were analyzed by untargeted metabolomics;ResultsV9 effectively improved the overall symptoms of the colitis model mice. H&E showed that V9 re-stored the intestinal tissue structure. ELISA showed that V9 decreased the levels of IL-6, IL-22, and TNF-α and increased IL-10, SP, VIP, and 5-HT. V9 increased the expression of AHR, CYP1A1, MUC2, Claudin-3, Occludin, and ZO-1, and decreased 5-hydroxytryptamine transporter and Claudin-2. V9 increased the abundance of gut microbiota in colitis mice to promote the growth of beneficial bacteria. V9 increased tryptophan metabolites, and short-chain fatty acids, and improved gut inflammation.ConclusionV9 attenuates intestinal inflammation, improves the mucosal barrier, modulates intestinal microecology and exerts a protective effect in a mouse model of DSS-induced colitis.https://www.frontiersin.org/articles/10.3389/fmed.2025.1496023/fullBifidobacterium lactis V9ulcerative colitisintestinal barrierintestinal floratryptophan metabolism
spellingShingle Xiaoyan Duan
Xiaoyan Duan
Xiaoyan Duan
Xiaoyan Duan
Rilige Wu
Jianbo Li
Jianbo Li
Zeya Li
Yanqi Liu
Ping Chen
Bangmao Wang
Bangmao Wang
Bangmao Wang
Studies on the alleviating effect of Bifidobacterium lactis V9 on dextran sodium sulfate-induced colitis in mice
Frontiers in Medicine
Bifidobacterium lactis V9
ulcerative colitis
intestinal barrier
intestinal flora
tryptophan metabolism
title Studies on the alleviating effect of Bifidobacterium lactis V9 on dextran sodium sulfate-induced colitis in mice
title_full Studies on the alleviating effect of Bifidobacterium lactis V9 on dextran sodium sulfate-induced colitis in mice
title_fullStr Studies on the alleviating effect of Bifidobacterium lactis V9 on dextran sodium sulfate-induced colitis in mice
title_full_unstemmed Studies on the alleviating effect of Bifidobacterium lactis V9 on dextran sodium sulfate-induced colitis in mice
title_short Studies on the alleviating effect of Bifidobacterium lactis V9 on dextran sodium sulfate-induced colitis in mice
title_sort studies on the alleviating effect of bifidobacterium lactis v9 on dextran sodium sulfate induced colitis in mice
topic Bifidobacterium lactis V9
ulcerative colitis
intestinal barrier
intestinal flora
tryptophan metabolism
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1496023/full
work_keys_str_mv AT xiaoyanduan studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT xiaoyanduan studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT xiaoyanduan studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT xiaoyanduan studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT riligewu studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT jianboli studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT jianboli studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT zeyali studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT yanqiliu studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT pingchen studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT bangmaowang studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT bangmaowang studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice
AT bangmaowang studiesonthealleviatingeffectofbifidobacteriumlactisv9ondextransodiumsulfateinducedcolitisinmice